Galenus Pharmaceuticals SA

Company Profile

GALENUS Pharmaceuticals S.A specializes in the sales of generic medicines and the representation of original medicinal drugs involving the central nervous system, such as antidepressants, neuroleptics, anticonvulsants, antiparkinson agents, migraine relief and medicine used to slow down the process of dementia (Alzheimer’s disease) guaranteeing quality at competitive prices.

Galenus is dedicated to developing a line of evolutionary drugs at economy prices used to aid in the prevention and treatment of major diseases of the C.N.S affecting the general population. Our goal is to reach the highest standards of development, production and promotion of effective substances and high quality products, offering both doctors and patients a worthy alternative at reasonable prices.

Quality Control is based on scientific knowledge and the implementation of procedures enforced by the American F.D.A and the European G.M.P as well as International rules and regulations.